SLP Key Statistics, Chart & Performance
The current stock price of SLP is 19.035 USD. In the past month the price decreased by -6.3%. In the past year, price decreased by -32.04%.
SLP Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 30.55 | 38.87B | ||
| DOCS | DOXIMITY INC-CLASS A | 27.83 | 8.59B | ||
| WAY | WAYSTAR HOLDING CORP | 24.08 | 6.17B | ||
| HTFL | HEARTFLOW INC | N/A | 2.60B | ||
| CERT | CERTARA INC | 18.81 | 1.50B | ||
| SDGR | SCHRODINGER INC | N/A | 1.38B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.40B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.08B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 641.25 | 1.09B | ||
| PHR | PHREESIA INC | N/A | 1.03B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 8.19 | 972.47M | ||
| HSTM | HEALTHSTREAM INC | 33.87 | 683.30M |
Related stock screener links
About SLP
Company Profile
Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The company is headquartered in Research Triangle Park, North Carolina and currently employs 212 full-time employees. The company operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The firm operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. The company delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
Company Info
SIMULATIONS PLUS INC
800 Park Offices Drive, Suite 401
RESEARCH TRIANGLE PARK NORTH CAROLINA 93534 US
CEO: Shawn O'Connor
Employees: 245
Phone: 16617237723
SIMULATIONS PLUS INC / SLP FAQ
What does SIMULATIONS PLUS INC do?
Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The company is headquartered in Research Triangle Park, North Carolina and currently employs 212 full-time employees. The company operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The firm operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. The company delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
Can you provide the latest stock price for SIMULATIONS PLUS INC?
The current stock price of SLP is 19.035 USD. The price decreased by -0.86% in the last trading session.
Does SIMULATIONS PLUS INC pay dividends?
SIMULATIONS PLUS INC (SLP) has a dividend yield of 0.61%. The yearly dividend amount is currently 0.
What is the ChartMill technical and fundamental rating of SLP stock?
SLP has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Where is SIMULATIONS PLUS INC (SLP) stock traded?
SLP stock is listed on the Nasdaq exchange.
What sector and industry does SIMULATIONS PLUS INC belong to?
SIMULATIONS PLUS INC (SLP) operates in the Health Care sector and the Health Care Technology industry.
Can you provide the number of employees for SIMULATIONS PLUS INC?
SIMULATIONS PLUS INC (SLP) currently has 245 employees.
SLP Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to SLP. When comparing the yearly performance of all stocks, SLP is a bad performer in the overall market: 67.69% of all stocks are doing better.
SLP Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to SLP. SLP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
SLP Financial Highlights
Over the last trailing twelve months SLP reported a non-GAAP Earnings per Share(EPS) of 0.58. The EPS increased by 18.37% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -49.05% | ||
| ROE | -51.86% | ||
| Debt/Equity | 0 |
SLP Forecast & Estimates
11 analysts have analysed SLP and the average price target is 23.46 USD. This implies a price increase of 23.25% is expected in the next year compared to the current price of 19.035.
For the next year, analysts expect an EPS growth of 32.34% and a revenue growth 1.9% for SLP